期刊文献+

子宫腺肌病灶细胞对米非司酮作用的敏感性实验研究 被引量:2

The experimental study of the effects of mifepristone on adenomyotic cells in vitro
下载PDF
导出
摘要 目的观察子宫腺肌病灶组织细胞对米非司酮作用的敏感性。方法采用噻唑兰法观察米非司酮对22例子宫腺肌病患者腺肌病灶组织原代培养细胞体外生长状态的影响。实验分为1.25mg/L、2.5mg/L、5.0mg/L,3个药物浓度组,培养52h,测定OD值,并与空白对照组对比。结果1.25mg/L、2.5mg/L、5.0mg/L组及对照组的OD值分别为(0.219±0.044)(、0.185±0.038)(、0.152±0.033)、(0.262±0.068),5.0与1.25mg/L组有显著差异(P<0.01),5.0mg/L、2.5mg/L组与对照组有显著差异(P<0.01)。细胞生长抑制率2.5mg/L组(IR=29.5%)是1.25mg/L组(IR=16.6%)的1.79倍,5.0mg/L组(IR=42.0%)是2.5mg/L组的1.43倍。结论米非司酮抑制子宫腺肌病腺肌组织细胞的生长能力与药物浓度呈正相关。 Objective To observe the effects of mifepristone on the cultured adenomyotic cells. Methods With MTT assay,the growth state of premary cell culture trom adenomyotic implants of 11 women with adenomyosis was studied.The cells of each case were deveded into foru groups,three treat ment groups(1.25mg/L,2.5mg/L,5.0mg/L mifepristone,respectively) and one control group.cultured for 52 hours before the OD value was determined.Results The OD values of 1.25mg/L,2.5mg/L,5.0mg/L mifepristone and control group were (0.219±0.044),0.185±0.038) and (0.262±0.068) respectively.The OD value of 5.0mg/L groups had significantly lower OD values than the control group(P<0.01),and both 5.0mg/L and 2.5mg/L groups had segnificantly lower OD values than the control group(P<0.01).The inhibition rate of cell growth in 2.5mg/L group (IR=29.4%) was 1.79 times as much as that in 1.25mg/L,group(IR=16.4%),while in 5.0mg/L group (IR=42.0%) it was 1.43 times as much as that in 2.5mg/L group.Conclusion Mifepristone could suppress the growth of adenomyotic cells in vitro in a dose dependent manner.
出处 《菏泽医学专科学校学报》 2005年第2期1-3,共3页 Journal of Heze Medical College
关键词 子宫腺肌病/治疗 非米司酮/治疗作用 细胞培养 噻唑兰 adenomyosis/therapy mifepristone/therapertic use cell culture MTT
  • 相关文献

参考文献7

二级参考文献43

共引文献242

同被引文献14

  • 1彭小新,黄志欣,王春平,吴建平,郭蓉.阴道超声和腹部超声诊断子宫腺肌病的比较研究[J].河北医学,2006,12(2):113-114. 被引量:21
  • 2何立红,何淑明.彩色多普勒超声对子宫腺肌病的诊断价值[J].实用临床医学(江西),2006,7(4):113-115. 被引量:5
  • 3孙秋英 谢红宁.妇产科影像诊断与介入治疗学[M].北京:人民卫生出版社,2001.197-200.
  • 4乐杰.妇产科学[M].第6版.北京:人民卫生出版社,2005.262.
  • 5杨太珠.实用妇产科超声诊断图解[M].北京:化学工业出版社,2006:128
  • 6Bazot M, Darai E, Hourani R, et al. Deep pelvic endometriosis: Mr imaging for diagnosis and prediction of extension of disease[J]. Radiology, 2004, 232(2): 379-389.
  • 7González-Ramos R, Rocco J, Rojas C, et al. Physiologic activation of nuclear factor kappa-B in the endometrium during the menstrual cycle is altered in endometriosis patients[J]. Fertil Steril, 2012, 97(3): 645-651.
  • 8Ying TH, Tseng CJ, Tsai SJ, et al. Assiociation of p53 and CD-KN1A genotypes with endometriosis[J]. Anticancer Res, 2011, 31(12): 4301-4306.
  • 9Bazot M, Dara? E, Rouger J, et al. Limitations of transvaginal sonography for the diagnosis of adenomyosis, with histopathological correlation[J]. Ultrasound Obstet Gynecol, 2002, 20(6): 605-611.
  • 10孙良,赵明珠.腹壁切口下子宫内膜异位症超声诊断价值[J].实用医技杂志,2011,18(11):1159-1160. 被引量:4

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部